← Back to Search

Antimicrobial Photodynamic Therapy

Saline irrigation for Chronic Sinusitis

N/A
Waitlist Available
Led By Martin Desrosiers, MD
Research Sponsored by Ondine Biomedical Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

Study Summary

The purpose of this study is to determine whether the use of light and a topically applied photosensitizer can relieve symptoms and clinically improve patients with chronic rhinosinusitis.

Eligible Conditions
  • Chronic Sinusitis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
SNOT-22
Secondary outcome measures
Microbiome evaluation
Other outcome measures
CT Scoring
Endoscopic Evaluation Scoring
Nasal and sinus symptom score
+1 more

Trial Design

3Treatment groups
Active Control
Group I: Saline irrigationActive Control1 Intervention
Saline irrigation via syringe will be administered using a sinus irrigation catheter under endoscopic control.
Group II: Single photodisinfection treatmentActive Control1 Intervention
The single-treatment group will receive a single photodisinfection treatment of all involved paranasal sinuses with multiple follow-up visits.
Group III: Double photodisinfection treatmentActive Control1 Intervention
Patients in the double treatment arm will receive a second photodisinfection treatment 4 weeks following the first treatment with regular follow-up visits

Find a Location

Who is running the clinical trial?

Ondine Biomedical Inc.Lead Sponsor
4 Previous Clinical Trials
481 Total Patients Enrolled
Martin Desrosiers, MDPrincipal InvestigatorUniversité de Montréal

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~4 spots leftby Apr 2025